Samuel Funt, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Oncology)
    Ineligible company: 
    AstraZeneva
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Oncology)
    Ineligible company: 
    Genetech/Roche
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Merck
  • Attribution: 
    Self
    Type of financial relationship: 
    Investment Interest (Oncology)
    Ineligible company: 
    Urogen Pharma
  • Attribution: 
    Self
    Type of financial relationship: 
    Investment Interest (Oncology)
    Ineligible company: 
    Allogene Therapeutics
  • Attribution: 
    Self
    Type of financial relationship: 
    Investment Interest (Oncology)
    Ineligible company: 
    Neogene Therapeutics
Return to Update Series (2023) Lesson 10: The Evolving Management of Testicular Seminoma